Section R. 338.3101 - Definitions; A to HRule 1. As used in these rules:
(a) "ASAP" means the American Society for Automation in Pharmacy.(b) "Automated device" means a mechanical system that performs an operation or activity, other than compounding or administration, relating to the storage, packaging, dispensing, or delivery of a drug and that collects, controls, and maintains transaction information.(c) "Board" means the board of pharmacy.(d) "CMS" means the United States Centers for Medicare and Medicaid Services.(e) "Code" means the public health code, 1978 PA 368, MCL 333.1101 to 333.25211.(f) "CSA" means the controlled substances act, Public Law 91-513.(g) "DEA" means the United States Drug Enforcement Administration.(h) "Department" means the department of licensing and regulatory affairs.(i) "Electronic signature" means an electronic sound, symbol, or process attached to or associated with a record and executed or adopted by an individual with the intent to sign the record. An electronic signature also is a unique identifier protected by appropriate security measures that is only available for use by the intended individual and ensures nonrepudiation so that the signature may not be rejected based on its validity.(j) "FDA" means the United States Food and Drug Administration.(k) "FDCA" means the Federal Food, Drug, and Cosmetic Act, 21 USC 301 to 399g.Mich. Admin. Code R. 338.3101
1979 AC; 1992 AACS; 2002 AACS; 2004 AACS; 2022 AACS; 2024 MR 10, Eff. 5/28/2024